1
|
Luna-Garza DK, Aguilar-Calderón PE, Rodriguez-Tamez G, Brown-Herrera A, Brussolo-Marroquin E, Ocampo-Candiani J, Alba-Rojas EL. Acute erythematous pustular plaques on the hands triggered by driving. Indian J Dermatol Venereol Leprol 2024; 0:1-3. [PMID: 38841946 DOI: 10.25259/ijdvl_1143_2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 12/15/2023] [Indexed: 06/07/2024]
Affiliation(s)
- Debanhi K Luna-Garza
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| | - Patrizia E Aguilar-Calderón
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| | - Giselle Rodriguez-Tamez
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| | - Alejandra Brown-Herrera
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| | - Elizabeth Brussolo-Marroquin
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| | - Jorge Ocampo-Candiani
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| | - Erika L Alba-Rojas
- Department of Dermatology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av. Madero and Gonzalitos Mitras Centro, Monterrey, Mexico
| |
Collapse
|
2
|
Jalili A, Bewley A, Sticherling M, Stein Gold L. Short Term and Long-Term Efficacy of Calcipotriene/ Betamethasone Dipropionate Foam Combination. CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY 2022; 15:809-814. [PMID: 35531463 PMCID: PMC9075015 DOI: 10.2147/ccid.s361884] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/16/2022] [Accepted: 04/15/2022] [Indexed: 11/23/2022]
Abstract
Psoriasis is a well-known chronic disease characterized by the development of erythematous, indurated, scaly, pruritic plaques on the skin with cycles of remission and symptom flare-ups. The management of patients with chronic plaque psoriasis has been more challenging since the Covid-19 pandemic as health care professionals have had to adapt to remote consultations for some patients, and patients have had to adapt to the changing health landscape. The rapid resolution of psoriasis symptoms especially those with a substantial impact on quality of life can improve patient satisfaction and adherence, making it an important factor in successful treatment. Cal/BD foam contributes to improved patient adherence and treatment outcome through its rapid action and superior efficacy versus Cal or BD monotherapy, Cal/BD ointment and gel and clobetasol cream in the short-term flare treatment of psoriasis. Moreover, the benefits of proactive long-term management of psoriasis compared to reactive management and its favourable safety profile are higher efficacy and a better health-related quality of life. Cal/BD foam should be considered an effective topical treatment for short-term flare treatment and long-term control of adult psoriatic patients.
Collapse
Affiliation(s)
- Ahmad Jalili
- Dermatology & Skin Care Clinic, Buochs, Switzerland
| | - Anthony Bewley
- Barts Health NHS Trust and Queen Mary University London, London, UK
| | - Michael Sticherling
- Department of Dermatology, Psoriasis Center, University Medical Center, Erlangen, Germany
| | - Linda Stein Gold
- Department of Dermatology, Henry Ford Health System, Detroit, MI, USA
| |
Collapse
|
3
|
Joshi TP, Friske SK, Hsiou DA, Duvic M. New Practical Aspects of Sweet Syndrome. Am J Clin Dermatol 2022; 23:301-318. [PMID: 35157247 PMCID: PMC8853033 DOI: 10.1007/s40257-022-00673-4] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/19/2022] [Indexed: 12/12/2022]
Abstract
Sweet syndrome (SS), or acute febrile neutrophilic dermatosis, is an inflammatory, non-infectious skin reaction characterized clinically by tender, erythematous papules/plaques/pustules/nodules commonly appearing on the upper limbs, trunk, and head and neck; histologically, SS is characterized by dense neutrophilic infiltrate in the dermis. SS is accompanied by fever; an elevation of inflammatory markers (e.g., erythrocyte sedimentation rate, C reactive protein) in serum may also be observed. Although most cases of SS are idiopathic, SS also occurs in the setting of malignancy or following administration of an associated drug. SS has also been reported in association with pregnancy and a burgeoning list of infectious (most commonly upper respiratory tract infections) and inflammatory diseases; likewise, the litany of possible iatrogenic triggers has also grown. Over the past several years, a wider spectrum of SS presentation has been realized, with several reports highlighting novel clinical and histological variants. Corticosteroids continue to be efficacious first-line therapy for the majority of patients with SS, although novel steroid-sparing agents have been recently added to the therapeutic armamentarium against refractory SS. New mechanisms of SS induction have also been recognized, although the precise etiology of SS still remains elusive. Here, we catalogue the various clinical and histological presentations of SS, summarize recently reported disease associations and iatrogenic triggers, and review treatment options. We also attempt to frame the findings of this review in the context of established and emerging paradigms of SS pathogenesis.
Collapse
|
4
|
The Brain-Skin Axis in Psoriasis-Psychological, Psychiatric, Hormonal, and Dermatological Aspects. Int J Mol Sci 2022; 23:ijms23020669. [PMID: 35054853 PMCID: PMC8776235 DOI: 10.3390/ijms23020669] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Revised: 01/05/2022] [Accepted: 01/06/2022] [Indexed: 02/04/2023] Open
Abstract
Psoriasis is a chronic inflammatory skin disease with systemic manifestation, in which psychological factors play an important role. The etiology of psoriasis is complex and multifactorial, including genetic background and environmental factors such as emotional or physical stress. Psychological stress may also play a role in exacerbation of psoriasis, by dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, sympathetic–adrenal–medullary axis, peripheral nervous system, and immune system. Skin cells also express various neuropeptides and hormones in response to stress, including the fully functional analog of the HPA axis. The deterioration of psoriatic lesions is accompanied by increased production of inflammatory mediators, which could contribute to the imbalance of neurotransmitters and the development of symptoms of depression and anxiety. Therefore, deregulation of the crosstalk between endocrine, paracrine, and autocrine stress signaling pathways contributes to clinical manifestations of psoriasis, which requires multidisciplinary approaches.
Collapse
|
5
|
Papp K, Adamski Z, Guenther L, Liljedahl M, Miasik-Pogodzinska A, Szponar-Bojda A, Lynde C, Nutt T, Mørch MH, Tyring S, Werschler W, Reich A, Sadick N, Turchin I, Lacour JP. Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis. J DERMATOL TREAT 2021; 33:2297-2304. [PMID: 34365872 DOI: 10.1080/09546634.2021.1959501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
OBJECTIVE In PSO-LONG, long-term proactive management (PAM) of psoriasis with fixed-dose combination calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g (Cal/BD) aerosol foam was superior to conventional reactive management. This post-hoc analysis investigated long-term PAM with Cal/BD foam in PSO-LONG patients who could be more susceptible to corticosteroid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression. METHODS Efficacy and safety of PAM with Cal/BD foam (twice-weekly) versus reactive management (twice-weekly vehicle foam), with once-daily rescue Cal/BD foam for four weeks following relapse, was assessed in the HPA subgroup (n = 66); patients had moderate-to-severe psoriasis (physician global assessment score ≥3; 10-30% body surface area affected). Primary endpoint was time to first relapse. RESULTS PAM with Cal/BD foam was associated with longer median time to first relapse (111 versus 31 days), reduced risk of first relapse (hazard ratio: 0.49; p = .029), greater proportion of days in remission (17%; p = .001) and reduced rate of relapse (60% reduction; p < .001) than reactive management. Adverse events occurred in 37.5% (PAM) and 47.1% (reactive management) of patients, with no new safety signals. No clinically significant HPA-axis suppression was observed. CONCLUSION Efficacy of PAM with Cal/BD foam is maintained in patients with moderate-to-severe psoriasis, with no new safety signals.
Collapse
Affiliation(s)
- Kim Papp
- K. Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada
| | - Zygmunt Adamski
- Department of Dermatology, University of Medical Sciences, Poznań, Poland
| | | | | | | | | | - Charles Lynde
- Lynde Dermatology and Probity Medical Research, Markham, ON, Canada.,Department of Medicine, University of Toronto, Toronto, ON, Canada
| | - Terri Nutt
- San Antonio Skin Care and Dermatology Clinic, Shavano Park, TX, USA
| | | | - Stephen Tyring
- Department of Dermatology, Center for Clinical Studies, University of Texas Health Science Center, Houston, TX, USA
| | | | - Adam Reich
- Department of Dermatology, University of Rzeszów, Rzeszów, Poland
| | - Neil Sadick
- Department of Dermatology, Weill Medical College of Cornell University, New York, NY, USA
| | - Irina Turchin
- Brunswick Dermatology Centre, Fredericton, NB, Canada
| | | |
Collapse
|
6
|
Lebwohl M, Warren RB. Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis. J Eur Acad Dermatol Venereol 2021; 35 Suppl 1:3-4. [PMID: 33619781 PMCID: PMC8151871 DOI: 10.1111/jdv.17026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Video abstract
Collapse
Affiliation(s)
- M Lebwohl
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - R B Warren
- Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, UK
| |
Collapse
|